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Pharm. Bull. (1987) Synthesis ester. Further treatment with ethyl glycinate and taurine provided the glycine (7) and taurine (8) conjugates, respectively. Upon metal hydride reduction these conjugates were transformed into 7a-hydroxylated compounds (10, 11), which, on sulfation followed by elimination of the protecting groups, were converted to the desired glycine-and taurine-conjugated cholate 7,12-disulfates (13, 14). The synthesis of cholate 3,7-disulfates was then undertaken. Methyl cholate 3,12-diacetate, formed from 2 by usual acetylation with acetic anhydride in pyridine and metal hydride reduction, was converted to cholic acid 12-monoacetate (15) by brief exposure to 5% methanolic sodium hydroxide. In a similar fashion 15 was transformed into the p-nitrophenyl ester, which in turn was condensed with ethyl glycinate and taurine to yield the glycine (17) and taurine (18) conjugates. Treatment of the resulting cholate 12-monoacetates (16, 17, 18) with sulfur trioxide-triethylamine complex in pyridine and subsequent alkaline hydrolysis afforded the desired 3,7-disulfated cholates (19, 20, 21) . Next, preparation of cholate 3,12-disulfates was carried out. Condensation of 1 with pnitrophenol yielded the p-nitrophenyl ester, which, on treatment with ethyl glycinate and taurine, were led to glycine (3) and taurine (4) conjugates, respectively. Compounds 2, 3 and 4 were subjected to sulfation in the same manner as described above followed by borohydride reduction and elimination of the protecting groups, providing the desired cholate 3,12-disulfates (22, 23, 24 
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